Sökning: onr:"swepub:oai:lup.lub.lu.se:d95d9fcc-b871-4b11-90e4-9edca8ce91fd" >
Benefits and harms ...
Benefits and harms of high-dose haemodiafiltration versus high-flux haemodialysis : The comparison of high-dose haemodiafiltration with high-flux haemodialysis (CONVINCE) trial protocol
-
- Blankestijn, Peter J. (författare)
- University Medical Center Utrecht
-
- Fischer, Kathrin I. (författare)
- Charité - University Medicine Berlin
-
Barth, Claudia (författare)
-
visa fler...
-
- Cromm, Krister (författare)
- Fresenius Medical Care Deutschland GmbH
-
- Canaud, Bernard (författare)
- Fresenius Medical Care Deutschland GmbH,University of Montpellier
-
- Davenport, Andrew (författare)
- University College London
-
- Grobbee, Diederick E. (författare)
- University Medical Center Utrecht,Julius Clinical
-
- Hegbrant, Jörgen (författare)
- Lund University,Lunds universitet,Njurmedicin,Sektion II,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Nephrology,Section II,Department of Clinical Sciences, Lund,Faculty of Medicine
-
- Roes, Kit C. (författare)
- University Medical Center Utrecht
-
- Rose, Matthias (författare)
- Charité - University Medicine Berlin,University of Massachusetts Medical School
-
- Strippoli, Giovanni F.M. (författare)
- University of Sydney,University of Bari Aldo Moro
-
- Vernooij, Robin W.M. (författare)
- University Medical Center Utrecht
-
- Woodward, Mark (författare)
- University of New South Wales,Johns Hopkins University,University of Oxford
-
- De Wit, G. Ardine (författare)
- University Medical Center Utrecht,National Institute for Public Health and the Environment (RIVM)
-
- Bots, Michiel L. (författare)
- University Medical Center Utrecht
-
visa färre...
-
(creator_code:org_t)
- 2020-02-05
- 2020
- Engelska.
-
Ingår i: BMJ Open. - : BMJ. - 2044-6055. ; 10:2
- Relaterad länk:
-
http://dx.doi.org/10... (free)
-
visa fler...
-
https://bmjopen.bmj....
-
https://lup.lub.lu.s...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- Introduction End-stage kidney disease (ESKD) is a major public health problem affecting more than 2 million people worldwide. It is one of the most severe chronic non-communicable diseases. Haemodialysis (HD) is the most common therapeutic option but is also associated with a risk of cardiovascular events, hospitalisation and suboptimal quality of life. Over the past decades, haemodiafiltration (HDF) has become available. Although high-dose HDF has shown some promising survival advantage compared to conventional HD, the evidence remains controversial. A Cochrane systematic review found, in low-quality trials, with various convective forms of dialysis, a reduction in cardiovascular, but not all-cause mortality and the effects on non-fatal cardiovascular events and hospitalisation were uncertain. In contrast, an individual patient data analysis suggested that high-dose HDF reduced both all-cause and cardiovascular mortality compared to HD. In view of these discrepant results, a definitive trial is required to determine whether high-dose HDF is preferable to high-flux HD. The comparison of high-dose HDF with high-flux HD (CONVINCE) study will assess the benefits and harms of high-dose HDF versus a conventional high-flux HD in adults with ESKD. Methods and analysis This international, prospective, open label, randomised controlled trial aims to recruit 1800 ESKD adults treated with HD in nine European countries. Patients will be randomised 1:1 to high-dose HDF versus continuation of conventional high-flux HD. The primary outcome will be all-cause mortality at 3 years' follow-up. Secondary outcomes will include cause-specific mortality, cardiovascular events, all-cause and infection-related hospitalisations, patient-reported outcomes (eg, health-related quality of life) and cost-effectiveness. Ethics and dissemination The CONVINCE study will address the question of benefits and harms of high-dose HDF compared to high-flux HD for kidney replacement therapy in patients with ESKD with a focus on survival, patient perspectives and cost-effectiveness. Trial registration number Netherlands National Trial Register (NTR 7138).
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Urologi och njurmedicin (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Urology and Nephrology (hsv//eng)
Nyckelord
- end-stage kidney disease
- haemodiafiltration
- haemodialysis
- protocol
- randomised controlled trial
Publikations- och innehållstyp
- art (ämneskategori)
- ref (ämneskategori)
Hitta via bibliotek
-
BMJ Open
(Sök värdpublikationen i LIBRIS)
Till lärosätets databas
- Av författaren/redakt...
-
Blankestijn, Pet ...
-
Fischer, Kathrin ...
-
Barth, Claudia
-
Cromm, Krister
-
Canaud, Bernard
-
Davenport, Andre ...
-
visa fler...
-
Grobbee, Diederi ...
-
Hegbrant, Jörgen
-
Roes, Kit C.
-
Rose, Matthias
-
Strippoli, Giova ...
-
Vernooij, Robin ...
-
Woodward, Mark
-
De Wit, G. Ardin ...
-
Bots, Michiel L.
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Urologi och njur ...
- Artiklar i publikationen
-
BMJ Open
- Av lärosätet
-
Lunds universitet